Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 safety, tolerability, and pharmacokinetic study of TV-44749 in Chinese patients with schizophrenia has been completed, sponsored by Teva Branded Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• TV-44749

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED